Showing results (1771-1780 of 1,841) with videos related to
Sort By:
Pageof 185
Signal Transduction and Targeted Therapy|March 4, 2025
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccinesWenjing Xiao, Wenjie Jiang, Zheng Chen, et al.Signal Transduction and Targeted Therapy|February 27, 2025
Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trialDan-Yun Ruan, Wen-Wen Huang, Yongsheng Li, et al.Signal Transduction and Targeted Therapy|June 11, 2024
Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancerYun Yang, Qingya Liu, Meng Wang, et al.Signal Transduction and Targeted Therapy|May 29, 2024
Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltrationFenglian He, Zhongen Wu, Chenglong Liu, et al.Signal Transduction and Targeted Therapy|June 6, 2024
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trialHuizi Sha, Fan Tong, Jiayao Ni, et al.Signal Transduction and Targeted Therapy|June 8, 2024
Pathology of pain and its implications for therapeutic interventionsBo Cao, Qixuan Xu, Yajiao Shi, et al.Signal Transduction and Targeted Therapy|May 19, 2024
Tumor biomarkers for diagnosis, prognosis and targeted therapyYue Zhou, Lei Tao, Jiahao Qiu, et al.Signal Transduction and Targeted Therapy|May 17, 2024
PARP1-DNA co-condensation: the driver of broken DNA repairXiang Wei, Fangfang Zhou, Long ZhangSignal Transduction and Targeted Therapy|June 23, 2024
Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancerPengcheng Zhou, Xuanlong Du, Weilu Jia, et al.Signal Transduction and Targeted Therapy|May 13, 2024
Enhanced potency of an IgM-like nanobody targeting conserved epitope in SARS-CoV-2 spike N-terminal domainBo Liu, Honghui Liu, Pu Han, et al.Pageof 185